Skip to main content
All lobbying filings

GOVERNMENT COUNSEL, LLC

GOVERNMENT COUNSEL, LLC filed a Q2 report for APOTEX CORPORATION on July 20, 2026, reporting $30,000 in lobbying income.

Lobbying for APOTEX CORPORATION · Generic pharmaceutical manufacturer

All filings by GOVERNMENT COUNSEL, LLC · Everything APOTEX CORPORATION has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$30,000
What the client paid this registrant for the period.
Client based in
Florida

Official filing document

 Lobbyists on this filing 1
  • HENRY W MENN III
    Previously held: Chief of Staff, Sen. Bob Graham; Minority Staff Director & Counsel, Sen. Cmte on Veterans Affairs; Sp. Asst. Legislative Affairs, FDA Office of Commissioner.

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

 Lobbying activity 1

Federal policy relating to trade tariffs, strengthening domestic generic production and market access barriers for generic pharmaceuticals.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem